Mammary Fold Pre-ABS Meeting

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Oncotype DX Breast Recurrence Score^® Test and the Cologuard^® stool DNA-based colorectal cancer screening test¹ , Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.  The Oncotype DX^® test is the most commonly used genomic assay in the NHS for adjuvant chemotherapy treatment decision-making.

^{1.                    This product is only available in the US}